Evidence map›Paper›PMID 24363882›Full record

ArticleMediterranean journal of hematology and infectious diseases2013

Fournier's Gangrene Complicating Hematologic Malignancies: a Case Report and Review of Licterature.

Giovanni D'Arena, Giuseppe Pietrantuono, Emilio Buccino, Giancarlo Pacifico, Pellegrino Musto

Open access · goldAbstract readCase Reports
In one paragraph

Article in Mediterranean journal of hematology and infectious diseases, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Fournier's Gangrene: Clinical Presentation of 13 Cases.Medical science monitor : international medical journal of experimental and clinical research · 2018
    Article
  8. Article
  9. Anorectal Complications During Neutropenic Period in Patients with Hematologic Diseases.Mediterranean journal of hematology and infectious diseases · 2016
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Giovanni D'ArenaOnco-Hematology and Stem Cell Transplantation Unit, IRCCS "Centro di Riferimento Oncologico della Basilicata", Rionero in Vulture (Pz), Italy.
Giuseppe PietrantuonoOnco-Hematology and Stem Cell Transplantation Unit, IRCCS "Centro di Riferimento Oncologico della Basilicata", Rionero in Vulture (Pz), Italy.
Emilio BuccinoSurgical Department, "S. Giovanni di Dio" Hospital, Melfi (Pz), Italy.
Giancarlo PacificoSurgical Department, "S. Giovanni di Dio" Hospital, Melfi (Pz), Italy.
Pellegrino MustoScientific Direction, IRCCS "Centro di Riferimento Oncologico della Basilicata", Rionero in Vulture (Pz), Italy.
Centro di Riferimento Oncologico della Basilicata · ITNuovo Ospedale San Giovanni di Dio · ITIstituti di Ricovero e Cura a Carattere Scientifico · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fournier's gangrene (FG) is a rare but severe necrotizing fasciitis of the external genitalia that may complicate the clinical course of hematologic malignancies and sometimes may be the first sign of the disease. The clinical course of FG is very aggressive and the mortality is still high despite the improvement in its management. Early recognition of FG and prompt appropriate treatment with surgical debridement and administration of antibiotics are the cornerstone of the management of this very severe disease. A review of the scientific literature focusing on the topic of FG complicating hematologic disorders is reported.

Identifiers

PMID24363882
PMCPMC3867231
OpenAlexW2106054558

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.